The phagocytic capacity and immunological potency of human dendritic cells is improved by α2,6-sialic acid deficiency

Immunology

Volumn 138, Issue 3, 2013, Pages 235-245

  Cabral, M Guadalupe ^a   Silva, Zélia ^a   Ligeiro, Dário ^b   Seixas, Elsa ^a   Crespo, Hélio ^a   Carrascal, Mylène A ^a   Silva, Mariana ^a   Piteira, Ana R ^a   Paixão, Paulo ^a   Lau, Joseph T ^c   Videira, Paula A ^a  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b Ministerio da Saude Portuguese   (Portugal)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Dendritic cells; Immunological potency; Phagocytosis; Sialic acid

Indexed keywords

ALPHA2,6 SIALIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; SIALIC ACID; SIALIDASE; SIALYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; CELL FUNCTION; CELL MATURATION; DENDRITIC CELL; ENZYME ACTIVATION; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DENDRITIC CELLS; ESCHERICHIA COLI; HUMANS; MICE; MICE, KNOCKOUT; N-ACETYLNEURAMINIC ACID; PHAGOCYTOSIS; RHO GTP-BINDING PROTEINS;

EID: 84873294436     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12025     Document Type: Article

References (48)

1. Norbury CC. Drinking a lot is good for dendritic cells. Immunology 2006; 117:443-51.
2. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
4. Colino J, Snapper CM. Dendritic cells, new tools for vaccination. Microbes Infect 2003; 5:311-9.
5. Kis Z, Pallinger E, Endresz V, Burian K, Jelinek I, Gonczol E, Valyi-Nagy I. The interactions between human dendritic cells and microbes; possible clinical applications of dendritic cells. Inflamm Res 2004; 53:413-23.
6. Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008; 29:319-24.
7. Nakahashi A, Taniguchi T, Miura N, Monde K. Stereochemical studies of sialic acid derivatives by vibrational circular dichroism. Org Lett 2007; 9:4741-4.
8. Varki A. Sialic acids in human health and disease. Trends Mol Med 2008; 14:351-60.
9. O'Hanlon TP, Lau KM, Wang XC, Lau JT. Tissue-specific expression of β-galactoside α-2, 6-sialyltransferase. Transcript heterogeneity predicts a divergent polypeptide. J Biol Chem 1989; 264:17389-94.
10. Avril T, Attrill H, Zhang J, Raper A, Crocker PR. Negative regulation of leucocyte functions by CD33-related siglecs. Biochem Soc Trans 2006; 34(Pt 6):1024-7.
11. Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 2009; 113:3333-6.
12. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007; 7:255-66.
13. Khatua B, Ghoshal A, Bhattacharya K, Mandal C, Saha B, Crocker PR. Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition. FEBS Lett 2010; 584:555-61.
14. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol 2009; 19:507-14.
15. Severi E, Hood DW, Thomas GH. Sialic acid utilization by bacterial pathogens. Microbiology 2007; 153(Pt 9):2817-22.
16. Vimr E, Lichtensteiger C. To sialylate, or not to sialylate: that is the question. Trends Microbiol 2002; 10:254-7.
17. Crocker PR. Siglecs in innate immunity. Curr Opin Pharmacol 2005; 5:431-7.
18. Seyrantepe V, Iannello A, Liang F, Kanshin E, Jayanth P, Samarani S et al. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem 2010; 285:206-15.
19. Carrascal M, Silva Z, Crespo H, Cabral MG, Videira PA. Sialylation and Dendritic Cells: Bridging Innate and Adaptive Immune Responses, 1st edn. In: Specialist Periodical Reports (SPR) Carbohydrate Chemistry. Vol. 37. Cambridge, UK: Royal Society of Chemistry, 2011; 94-116.
20. Videira PA, Amado IF, Crespo HJ, Alguero MC, Dall'Olio F, Cabral MG et al. Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J 2008; 25:259-68.
21. Bax M, Garcia-Vallejo JJ, Jang-Lee J et al. Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins. J Immunol 2007; 179:8216-24.
22. Crespo HJ, Cabral MG, Teixeira AV, Lau JT, Trindade H, Videira PA. Effect of sialic acid loss on dendritic cell maturation. Immunology 2009; 128(Suppl 1):e621-31.
23. Julien S, Adriaenssens E, Ottenberg K, Furlan A, Courtand G, Vercoutter-Edouart AS et al. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology 2006; 16:54-64.
24. Trottein F, Schaffer L, Ivanov S et al. Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages. Glycoconj J 2009; 26:1259-74.
25. Cabral MG, Piteira AR, Silva Z, Ligeiro D, Brossmer R, Videira PA. Human dendritic cells contain cell surface sialyltransferase activity. Immunol Lett 2010; 131:89-96.
26. Silva Z, Tong Z, Cabral MG, Martins C, Castro R, Reis C et al. Sialyl Lewis(x)-dependent binding of human monocyte-derived dendritic cells to selectins. Biochem Biophys Res Commun 2011; 409:459-64.
27. Nasirikenari M, Chandrasekaran EV, Matta KL, Segal BH, Bogner PN, Lugade AA et al. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. J Leukoc Biol 2010; 87:457-66.
28. Nasirikenari M, Segal BH, Ostberg JR, Urbasic A, Lau JT. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood 2006; 108:3397-405.
29. Jones MB, Nasirikenari M, Feng L, Migliore MT, Choi KS, Kazim L et al. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis. J Biol Chem 2010; 285:25009-17.
30. Hennet T, Chui D, Paulson JC, Marth JD. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 1998; 95:4504-9.
31. Videira PA, Correia M, Malagolini N, Crespo HJ, Ligeiro D, Calais FM et al. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer 2009; 9:357.
32. Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, Trombetta S et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000; 102:325-34.
33. Shurin GV, Tourkova IL, Chatta GS, Schmidt G, Wei S, Djeu JY et al. Small rho GTPases regulate antigen presentation in dendritic cells. J Imol 2005; 174:3394-400.
34. Ghosh S, Hayden MS. New regulators of NF-κB in inflammation. Nat Rev Immunol 2008; 8:837-48.
35. Patil S, Pincas H, Seto J, Nudelman G, Nudelman I, Sealfon SC. Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase. BMC Syst Biol 2010; 4:137.
36. May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today 1998; 19:80-8.
37. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit Care 2008; 12(Suppl 4):S4.
38. Silva Z, Konstantopoulos K, Videira PA. The role of sugars in dendritic cell trafficking. Ann Biomed Eng 2012; 40:777-89.
39. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R et al. Neu1 desialylation of sialyl α-2, 3-linked β-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal 2010; 22:314-24.
40. Watanabe Y, Shiratsuchi A, Shimizu K, Takizawa T, Nakanishi Y. Stimulation of phagocytosis of influenza virus-infected cells through surface desialylation of macrophages by viral neuraminidase. Microbiol Immunol 2004; 48:875-81.
41. Stamatos NM, Carubelli I, van de Vlekkert D et al. LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity. J Leukoc Biol 2010; 88:1227-39.
42. Stamatos NM, Curreli S, Zella D, Cross AS. Desialylation of glycoconjugates on the surface of monocytes activates the extracellular signal-related kinases ERK 1/2 and results in enhanced production of specific cytokines. J Leukoc Biol 2004; 75:307-13.
43. Lock K, Zhang J, Lu J, Lee SH, Crocker PR. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 2004; 209:199-207.
44. Ando M, Tu W, Nishijima K, Iijima S. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem Biophys Res Commun 2008; 369:878-83.
45. Ghosh S, Bandulet C, Nitschke L. Regulation of B cell development and B cell signalling by CD22 and its ligands α2, 6-linked sialic acids. Int Immunol 2006; 18:603-11.
46. Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J Biol Chem 2003; 278:7469-75.
47. Woodard-Grice AV, McBrayer AC, Wakefield JK, Zhuo Y, Bellis SL. Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of α4β1 integrins. J Biol Chem 2008; 283:26364-73.
48. Karlsson H, Larsson P, Wold AE, Rudin A. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect Immun 2004; 72:2671-8.